Risk of Relapse Among Propensity Score Matched Multiple Sclerosis Patients Receiving Natalizumab or Platform Therapy in the US

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.862
https://www.valueinhealthjournal.com/article/S1098-3015(14)02792-2/fulltext
Title : Risk of Relapse Among Propensity Score Matched Multiple Sclerosis Patients Receiving Natalizumab or Platform Therapy in the US
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02792-2&doi=10.1016/j.jval.2014.08.862
First page : A391
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 376
Categories :
Tags :
Regions :
ViH Article Tags :